Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Incretins are gut derived hormones, released after the ingestion of food. Incretins are classified into glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Both the molecules are inactivated by enzyme Dipeptidyl Peptidase-4 (DPP-4).
Oral traditional anti-diabetic drugs, often fail to maintain the desired normal level of glucose, especially in the postprandial condition. This has resulted in a strong need for better therapeutics such as incretin based drugs. Incretin not only increases the secretion of insulin by acting on pancreatic beta cells, but also inhibits the release of glucagon by acting on the pancreatic alpha cells.
This report elaborates on the current development of the Incretin-based Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Eli Lilly and Company
Takeda Pharmaceutical Company
Johnson & Johnson
Merck & Co
Sanofi
GlaxoSmithKline
Boehringer Ingelheim
Novartis
AstraZeneca
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Glucagon-like Peptide-1 Receptor (GLP-1) Agonists
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
Application:
Oral Drugs
Injectable Drugs
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Incretin-based Drugs Industry Overview
-
1.1.1 Incretin-based Drugs Market Scope and Market Segments
-
1.1.2 Incretin-based Drugs Industry Characteristics
-
1.1.3 Global and China Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Incretin-based Drugs Production Value and Growth Rate (2017-2028)
-
1.2 Global Incretin-based Drugs Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Glucagon-like Peptide-1 Receptor (GLP-1) Agonists
-
1.2.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
-
1.3 Global Incretin-based Drugs Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Oral Drugs
-
1.3.2 Injectable Drugs
-
1.4 Market Analysis by Region
-
1.4.1 North America Incretin-based Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Incretin-based Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Incretin-based Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Incretin-based Drugs Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Incretin-based Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Incretin-based Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Incretin-based Drugs Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Incretin-based Drugs Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Incretin-based Drugs Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Incretin-based Drugs Industry Porter's Five Forces Model Analysis
-
2.2.3 Incretin-based Drugs Industry PEST Analysis
-
2.3 Incretin-based Drugs Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Incretin-based Drugs Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Incretin-based Drugs Industry
Chapter 3 Global and China Incretin-based Drugs Market, by Manufacturer
-
3.1 Global and China Incretin-based Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Incretin-based Drugs Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Incretin-based Drugs Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Incretin-based Drugs Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Incretin-based Drugs Market Top 3 Players
Chapter 4 Global and China Incretin-based Drugs Market, by Type (2017-2028)
-
4.1 Incretin-based Drugs Market Trend, by Type
-
4.2 Global Incretin-based Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Incretin-based Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Incretin-based Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Incretin-based Drugs Price Trend, by Type (2017-2028)
-
4.3 China Incretin-based Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Incretin-based Drugs Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Incretin-based Drugs Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Incretin-based Drugs Price Trend, by Type (2017-2028)
Chapter 5 Global and China Incretin-based Drugs Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Incretin-based Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Incretin-based Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Incretin-based Drugs Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Incretin-based Drugs Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Incretin-based Drugs Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Incretin-based Drugs Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Incretin-based Drugs Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Incretin-based Drugs Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Incretin-based Drugs Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Incretin-based Drugs Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Incretin-based Drugs Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Incretin-based Drugs Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Incretin-based Drugs Market Analysis
-
7.1 North America Incretin-based Drugs Market, by Type
-
7.2 North America Incretin-based Drugs Market, by Application
-
7.3 North America Incretin-based Drugs Market Analysis and Forecast, by Country
-
7.3.1 United States Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Incretin-based Drugs Market Analysis
-
8.1 Europe Incretin-based Drugs Market, by Type
-
8.2 Europe Incretin-based Drugs Market, by Application
-
8.3 Europe Incretin-based Drugs Market Analysis and Forecast, by Country
-
8.3.1 Germany Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Incretin-based Drugs Market Analysis
-
9.1 APAC Incretin-based Drugs Market, by Type
-
9.2 APAC Incretin-based Drugs Market, by Application
-
9.3 APAC Incretin-based Drugs Market Analysis and Forecast, by Country
-
9.3.1 China Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Incretin-based Drugs Market Analysis
-
10.1 Latin America, Middle East and Africa Incretin-based Drugs Market, by Type
-
10.2 Latin America, Middle East and Africa Incretin-based Drugs Market, by Application
-
10.3 Latin America, Middle East and Africa Incretin-based Drugs Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Incretin-based Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Incretin-based Drugs Company Profiles
-
11.1 Eli Lilly and Company
-
11.1.1 Eli Lilly and Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Eli Lilly and Company Incretin-based Drugs Product Profiles, Application and Specification
-
11.1.3 Eli Lilly and Company Incretin-based Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Takeda Pharmaceutical Company
-
11.2.1 Takeda Pharmaceutical Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Takeda Pharmaceutical Company Incretin-based Drugs Product Profiles, Application and Specification
-
11.2.3 Takeda Pharmaceutical Company Incretin-based Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Johnson & Johnson
-
11.3.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Johnson & Johnson Incretin-based Drugs Product Profiles, Application and Specification
-
11.3.3 Johnson & Johnson Incretin-based Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Merck & Co
-
11.4.1 Merck & Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Merck & Co Incretin-based Drugs Product Profiles, Application and Specification
-
11.4.3 Merck & Co Incretin-based Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Sanofi
-
11.5.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Sanofi Incretin-based Drugs Product Profiles, Application and Specification
-
11.5.3 Sanofi Incretin-based Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 GlaxoSmithKline
-
11.6.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 GlaxoSmithKline Incretin-based Drugs Product Profiles, Application and Specification
-
11.6.3 GlaxoSmithKline Incretin-based Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Boehringer Ingelheim
-
11.7.1 Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Boehringer Ingelheim Incretin-based Drugs Product Profiles, Application and Specification
-
11.7.3 Boehringer Ingelheim Incretin-based Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Novartis
-
11.8.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Novartis Incretin-based Drugs Product Profiles, Application and Specification
-
11.8.3 Novartis Incretin-based Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 AstraZeneca
-
11.9.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 AstraZeneca Incretin-based Drugs Product Profiles, Application and Specification
-
11.9.3 AstraZeneca Incretin-based Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Incretin-based Drugs Industry Investment Prospect and Risk Assessment
-
12.1 Incretin-based Drugs Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Incretin-based Drugs Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Global Incretin-based Drugs Production Value and Growth Rate (2017-2028)
-
Figure China Incretin-based Drugs Production Value and Growth Rate (2017-2028)
-
Figure Global Incretin-based Drugs Market Size and Growth Rate of Glucagon-like Peptide-1 Receptor (GLP-1) Agonists (2017-2028)
-
Figure Global Incretin-based Drugs Market Size and Growth Rate of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors (2017-2028)
-
Figure Global Incretin-based Drugs Market Size and Growth Rate of Oral Drugs (2017-2028)
-
Figure Global Incretin-based Drugs Market Size and Growth Rate of Injectable Drugs (2017-2028)
-
Figure North America Incretin-based Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Incretin-based Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Incretin-based Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Incretin-based Drugs Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Incretin-based Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Incretin-based Drugs Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Incretin-based Drugs Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Incretin-based Drugs Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Incretin-based Drugs Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Incretin-based Drugs Market Share, by Manufacturer in 2021
-
Figure Global and China Incretin-based Drugs Market Share, by Manufacturer in 2022
-
Table Global Incretin-based Drugs Sales Volume, by Type (2017-2028)
-
Table Global Incretin-based Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Global Incretin-based Drugs Sales Volume Share, by Type (2017-2028)
-
Table Global Incretin-based Drugs Sales Value, by Type (2017-2028)
-
Table Global Incretin-based Drugs Sales Value Share, by Type (2017-2028)
-
Figure Global Incretin-based Drugs Price Trend, by Type (2017-2028)
-
Table China Incretin-based Drugs Sales Volume, by Type (2017-2028)
-
Table China Incretin-based Drugs Sales Volume Share, by Type (2017-2028)
-
Figure China Incretin-based Drugs Sales Volume Share, by Type (2017-2028)
-
Table China Incretin-based Drugs Sales Value, by Type (2017-2028)
-
Table China Incretin-based Drugs Sales Value Share, by Type (2017-2028)
-
Figure China Incretin-based Drugs Price Trend, by Type (2017-2028)
-
Table Global Incretin-based Drugs Sales Volume, by Application (2017-2028)
-
Table Global Incretin-based Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Global Incretin-based Drugs Sales Volume Share, by Application (2017-2028)
-
Table Global Incretin-based Drugs Sales Value, by Application (2017-2028)
-
Table Global Incretin-based Drugs Sales Value Share, by Application (2017-2028)
-
Figure Global Incretin-based Drugs Sales Value Share, by Application (2017-2028)
-
Table China Incretin-based Drugs Sales Volume, by Application (2017-2028)
-
Table China Incretin-based Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Incretin-based Drugs Sales Volume Share, by Application (2017-2028)
-
Table China Incretin-based Drugs Sales Value, by Application (2017-2028)
-
Table China Incretin-based Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Incretin-based Drugs Sales Value Share, by Application (2017-2028)
-
Figure China Incretin-based Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure North America Incretin-based Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Incretin-based Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Incretin-based Drugs Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Incretin-based Drugs Production, Import, Consumption and Export (2017-2022)
-
Table North America Incretin-based Drugs Sales Volume, by Type (2017-2028)
-
Table North America Incretin-based Drugs Sales Volume Share, by Type (2017-2028)
-
Figure North America Incretin-based Drugs Sales Volume Share, by Type (2017-2028)
-
Table North America Incretin-based Drugs Sales Volume, by Application (2017-2028)
-
Table North America Incretin-based Drugs Sales Volume Share, by Application (2017-2028)
-
Figure North America Incretin-based Drugs Sales Volume Share, by Application (2017-2028)
-
Figure United States Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure United States Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Canada Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Table Europe Incretin-based Drugs Sales Volume, by Type (2017-2028)
-
Table Europe Incretin-based Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Europe Incretin-based Drugs Sales Volume Share, by Type (2017-2028)
-
Table Europe Incretin-based Drugs Sales Volume, by Application (2017-2028)
-
Table Europe Incretin-based Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Europe Incretin-based Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Germany Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Figure UK Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure UK Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Figure France Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure France Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Italy Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Spain Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Poland Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Russia Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Table APAC Incretin-based Drugs Sales Volume, by Type (2017-2028)
-
Table APAC Incretin-based Drugs Sales Volume Share, by Type (2017-2028)
-
Figure APAC Incretin-based Drugs Sales Volume Share, by Type (2017-2028)
-
Table APAC Incretin-based Drugs Sales Volume, by Application (2017-2028)
-
Table APAC Incretin-based Drugs Sales Volume Share, by Application (2017-2028)
-
Figure APAC Incretin-based Drugs Sales Volume Share, by Application (2017-2028)
-
Figure China Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure China Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Japan Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Figure India Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure India Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Incretin-based Drugs Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Incretin-based Drugs Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Incretin-based Drugs Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Incretin-based Drugs Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Incretin-based Drugs Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Incretin-based Drugs Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Incretin-based Drugs Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Incretin-based Drugs Sales Value and Growth Rate (2017-2028)
-
Table Eli Lilly and Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Eli Lilly and Company Product Profiles, Application and Specification
-
Table Eli Lilly and Company Incretin-based Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Takeda Pharmaceutical Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Takeda Pharmaceutical Company Product Profiles, Application and Specification
-
Table Takeda Pharmaceutical Company Incretin-based Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Johnson & Johnson Product Profiles, Application and Specification
-
Table Johnson & Johnson Incretin-based Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Merck & Co Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merck & Co Product Profiles, Application and Specification
-
Table Merck & Co Incretin-based Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi Product Profiles, Application and Specification
-
Table Sanofi Incretin-based Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GlaxoSmithKline Product Profiles, Application and Specification
-
Table GlaxoSmithKline Incretin-based Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Boehringer Ingelheim Product Profiles, Application and Specification
-
Table Boehringer Ingelheim Incretin-based Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Incretin-based Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AstraZeneca Product Profiles, Application and Specification
-
Table AstraZeneca Incretin-based Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
